Biopharmaceuticals investors
22 investors that name Biopharmaceuticals among their sectors are recorded here, among them 10 venture capital firms, 5 asset managers, 3 other investors and 3 private equity firms. Stated investment stages run from seed to buyout. Most are headquartered in the United States (11), Hong Kong SAR China (3) and Switzerland (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| 5AM Ventures biopharmaceuticals · drug delivery technologies · life science instruments |
Direct investor | Venture capital | Seed – Growth | San Francisco, United States |
| ACT Capital Management, LLC Biopharmaceuticals · Biotechnology · Life Sciences · Medical Technology |
Direct investor | Asset manager | Not stated | Wayne, United States |
| Axil Capital Partners biopharmaceuticals · platform technologies · medical devices · digital health |
Direct investor | Venture capital | Seed – Growth | Japan |
| Bluestem Capital Company, LLC healthcare · technology · real estate · food and beverage |
Direct investor | Private equity | Growth – Buyout | Sioux Falls, United States |
| Commodore Capital biopharmaceuticals · genetic medicines · cellular therapies |
Direct investor | Other | Not stated | New York, United States |
| Fountain Healthcare Partners Specialty Pharma · Biopharmaceuticals · Medical Devices · Diagnostics |
Direct investor | Venture capital | Seed – Series A | Dublin, Ireland |
| H.I.G. HealthBridge Medical devices · Biopharmaceuticals · Digital Health · Tools and Diagnostics |
Direct investor | Private equity | Growth | |
| Lateral Capital health care · industrial products · B2B software · medical devices |
Direct investor | Venture capital | Seed – Series A | Sarasota, United States |
| LAV Advanced Management Company Limited biopharmaceuticals · human therapeutics · medical devices · diagnostics |
Direct investor | Venture capital | Not stated | Grand Cayman, Cayman Islands |
| LAV Asset Management (Hong Kong) Limited biopharmaceuticals · human therapeutics · medical devices · diagnostics |
Direct investor | Other | Seed – Growth | Hong Kong, Hong Kong SAR China |
| Lightstone Ventures Biotech · Medtech · Biopharmaceuticals · Medical Technology |
Direct investor | Venture capital | Seed – Growth | Menlo Park, United States |
| New Leaf Venture Partners healthcare · biopharmaceuticals · digital health |
Direct investor | Venture capital | Not stated | Menlo Park, United States |
| New Region Securities Company Limited technology · electronics · automotive components · green energy |
Direct investor | Asset manager | Not stated | Hong Kong, Hong Kong SAR China |
| NovaQuest Capital Management biopharmaceuticals · animal health · life sciences · healthcare |
Direct investor | Other | Growth | Raleigh, United States |
| Novartis Venture Fund biotechnology · biopharmaceuticals · life sciences · healthcare |
Direct investor | Corporate venture | Seed – Growth | Basel, Switzerland |
| OrbiMed biopharmaceuticals · medical devices · diagnostics · digital health |
Direct investor | Asset manager | Seed – Growth | New York City, United States |
| Pura Vida Investments, LLC Medical Technology · Genomics & Diagnostics · Biopharmaceuticals · Health-tech |
Direct investor | Asset manager | Not stated | New York, United States |
| SCP Vitalife Partners life sciences · medical devices · biopharmaceuticals · diagnostics |
Direct investor | Venture capital | Seed – Series B | Tel-Aviv, Israel |
| Sirona Capital Management Pty Ltd healthcare · life sciences · medical technology · biopharmaceuticals |
Direct investor | Venture capital | Seed – Series A | |
| Solas BioVentures Management, LLC biopharmaceuticals · medical devices · digital health |
Direct investor | Venture capital | Seed – Series A | Chattanooga, United States |
| The Equity Club marketing technology · cosmetics · biopharmaceuticals · surface treatments |
Direct investor | Private equity | Buyout | Milano, Italy |
| Truth Capital (Hong Kong) Limited technology · biopharmaceuticals · consumer · new energy |
Direct investor | Asset manager | Not stated | Hong Kong, Hong Kong SAR China |